Trulicity

RSS

dulaglutide

Authorised
This medicine is authorised for use in the European Union.

Overview

Trulicity is a diabetes medicine used in adults with type 2 diabetes when the disease is not controlled well enough. It is used with exercise and diet suitable for controlling diabetes.

Trulicity can be used together with other diabetes medicines or it can be used on its own in patients who cannot take metformin.

Trulicity contains the active substance dulaglutide.

This EPAR was last updated on 05/07/2021

Authorisation details

Product details
Name
Trulicity
Agency product number
EMEA/H/C/002825
Active substance
dulaglutide
International non-proprietary name (INN) or common name
dulaglutide
Therapeutic area (MeSH)
Diabetes Mellitus, Type 2
Anatomical therapeutic chemical (ATC) code
A10BJ05
Publication details
Marketing-authorisation holder
Eli Lilly Nederland B.V.
Revision
16
Date of issue of marketing authorisation valid throughout the European Union
21/11/2014
Contact address

Papendorpseweg 83
3528 BJ Utrecht
The Netherlands

Product information

17/06/2021 Trulicity - EMEA/H/C/002825 - PSUSA/00010311/202009

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Drugs used in diabetes

  • Blood glucose lowering drugs, excl. insulins

Therapeutic indication

Trulicity is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

  • as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
  • in addition to other medicinal products for the treatment of diabetes.

For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5 and 5.1.

Assessment history

Changes since initial authorisation of medicine

Related content

How useful was this page?

Add your rating
Average
1 rating
1 rating
3 ratings